Recognized immune markers continue to protect their relevance for clinical selection-building in breast cancer remedy with even extended meanings. Estrogen receptor (ER) level must not only be categorized in good or unfavorable. Lower ER levels ≤10% of labeled cells should be handled in a different way (LoE 1a/A/AGO++). Tumors https://raymondt753scl2.blogchaat.com/profile